BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 16181946)

  • 1. Comparison of clinical and neurophysiologic responses to intrathecal baclofen bolus administration in moderate-to-severe spasticity after acquired brain injury.
    Stokic DS; Yablon SA; Hayes A
    Arch Phys Med Rehabil; 2005 Sep; 86(9):1801-6. PubMed ID: 16181946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placebo controlled utility and feasibility study of the H-reflex and flexor reflex in spastic children treated with intrathecal baclofen.
    Hoving MA; van Kranen-Mastenbroek VH; van Raak EP; Spincemaille GH; Hardy EL; Vles JS;
    Clin Neurophysiol; 2006 Jul; 117(7):1508-17. PubMed ID: 16759902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intrathecal baclofen bolus injection on temporospatial gait characteristics in patients with acquired brain injury.
    Horn TS; Yablon SA; Stokic DS
    Arch Phys Med Rehabil; 2005 Jun; 86(6):1127-33. PubMed ID: 15954050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective assessment of tizanidine for spasticity due to acquired brain injury.
    Meythaler JM; Guin-Renfroe S; Johnson A; Brunner RM
    Arch Phys Med Rehabil; 2001 Sep; 82(9):1155-63. PubMed ID: 11552184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-response relationship between the H-reflex and continuous intrathecal baclofen administration for management of spasticity.
    Stokic DS; Yablon SA; Hayes A; Vesovic-Potic V; Olivier J
    Clin Neurophysiol; 2006 Jun; 117(6):1283-9. PubMed ID: 16621691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of intrathecal baclofen therapy on spasticity in patients with brain injury].
    Dénes Z; Klauber A; Both B; Lóránd E
    Ideggyogy Sz; 2012 Jul; 65(7-8):243-8; discussion 248. PubMed ID: 23074844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Case report of intrathecal baclofen administration in a child with severe spasticity attributable to traumatic brain injury].
    Matsuda R; Nishimura F; Hirabayashi H; Motoyama Y; Mishima H; Park YS; Nakase H; Sakaki T
    Brain Nerve; 2009 Mar; 61(3):313-5. PubMed ID: 19301603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuously infused intrathecal baclofen over 12 months for spastic hypertonia in adolescents and adults with cerebral palsy.
    Meythaler JM; Guin-Renfroe S; Law C; Grabb P; Hadley MN
    Arch Phys Med Rehabil; 2001 Feb; 82(2):155-61. PubMed ID: 11239304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical study of intrathecal baclofen using a programmable pump for intractable spasticity.
    Guillaume D; Van Havenbergh A; Vloeberghs M; Vidal J; Roeste G
    Arch Phys Med Rehabil; 2005 Nov; 86(11):2165-71. PubMed ID: 16271565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and neurophysiologic assessment of strength and spasticity during intrathecal baclofen titration in incomplete spinal cord injury: single-subject design.
    Bowden M; Stokic DS
    J Spinal Cord Med; 2009; 32(2):183-90. PubMed ID: 19569466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal baclofen in children with spastic cerebral palsy: a double-blind, randomized, placebo-controlled, dose-finding study.
    Hoving MA; van Raak EP; Spincemaille GH; Palmans LJ; Sleypen FA; Vles JS;
    Dev Med Child Neurol; 2007 Sep; 49(9):654-9. PubMed ID: 17718820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intrathecal baclofen therapy to spasticity].
    Mizusawa H
    Rinsho Shinkeigaku; 2007 Nov; 47(11):951-3. PubMed ID: 18210845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticity.
    Bensmail D; Quera Salva MA; Roche N; Benyahia S; Bohic M; Denys P; Bussel B; Lofaso F
    Neurology; 2006 Oct; 67(8):1432-6. PubMed ID: 17060570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intrathecal baclofen bolus injection on lower extremity joint range of motion during gait in patients with acquired brain injury.
    Horn TS; Yablon SA; Chow JW; Lee JE; Stokic DS
    Arch Phys Med Rehabil; 2010 Jan; 91(1):30-4. PubMed ID: 19913780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of intrathecal baclofen therapy in persons with acquired brain injury: influence on outcome.
    Posteraro F; Calandriello B; Galli R; Logi F; Iardella L; Bordi L
    Brain Inj; 2013; 27(13-14):1671-5. PubMed ID: 24087852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limitations of intrathecal baclofen for spastic hemiparesis following stroke.
    Kofler M; Quirbach E; Schauer R; Singer M; Saltuari L
    Neurorehabil Neural Repair; 2009 Jan; 23(1):26-31. PubMed ID: 18796543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time course of the effect of a bolus dose of intrathecal baclofen on severe cerebral spasticity.
    Pohl M; Rockstroh G; Rückriem S; Mehrholz J; Pause M; Koch R; Strik H
    J Neurol; 2003 Oct; 250(10):1195-200. PubMed ID: 14586601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal baclofen therapy for severe spasticity: analysis on a series of 112 consecutive patients and future prospectives.
    Natale M; Mirone G; Rotondo M; Moraci A
    Clin Neurol Neurosurg; 2012 May; 114(4):321-5. PubMed ID: 22104692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of concentration and mode of intrathecal baclofen administration on soleus H-reflex in patients with muscle hypertonia.
    Stokic DS; Yablon SA
    Clin Neurophysiol; 2012 Nov; 123(11):2200-4. PubMed ID: 22595326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Dosing of Intrathecal Baclofen in the Treatment of Spasticity After Acquired Brain Injury.
    Maneyapanda MB; McCormick ZL; Marciniak C; Reger C
    PM R; 2017 Jun; 9(6):556-562. PubMed ID: 28082177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.